Integrin, alpha9 subunit blockade suppresses collagen-induced arthritis with minimal systemic immunomodulation

Shingo Sugahara1, Kaori Hanaoka1, Nobuchika Yamamoto1

  • 1Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.

Insights

Blocking alpha9, a novel target for rheumatoid arthritis (RA), suppressed arthritis development in mice by reducing fibroblast-like synoviocyte activation. This approach shows promise for joint inflammation therapy with minimal immune system impact.

Area of Science:

  • Immunology
  • Rheumatology
  • Molecular Biology

Background:

  • Integrin, alpha9 subunit (alpha9) is overexpressed in rheumatoid arthritis (RA) joints and preclinical models, preceding symptom onset.
  • Alpha9 is identified as a novel therapeutic target for RA due to its elevated expression in affected tissues.

Purpose of the Study:

  • To evaluate the pharmacological profile of an anti-alpha9 antibody in a collagen-induced arthritis (CIA) mouse model.
  • To investigate the mechanism of action for alpha9 blockade in arthritis, focusing on fibroblast-like synoviocyte (FLS) activation and immune responses.

Main Methods:

  • Administration of an anti-alpha9 antibody in CIA mice.
  • Assessment of arthritis development, plasma biomarkers, antibody formation, and immune cell populations in joints and spleen.
  • Evaluation of alpha9's role in mixed lymphocyte reaction (MLR) and delayed type hypersensitivity (DTH) in non-arthritic mice.

Main Results:

  • Anti-alpha9 antibody treatment suppressed arthritis development and decreased FLS-derived biomarkers in CIA mice.
  • Alpha9 blockade reduced immune cell accumulation in arthritic joints but not in the spleen.
  • No inhibitory effect of alpha9 blockade was observed in MLR or DTH reactions in non-arthritic mice.
  • Therapeutic administration of anti-alpha9 antibody alleviated established arthritis.

Conclusions:

  • Alpha9 blockade exerts anti-arthritic effects by suppressing FLS activation through a non-immune mediated mechanism.
  • Targeting alpha9 offers a promising therapeutic strategy for joint inflammation in RA with minimal systemic immunomodulation.
  • Anti-alpha9 therapy is effective in both preventing and treating established arthritis in a preclinical model.

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.1K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.1K
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
3.4K